ABSTRACT Carcinoma-associated fibroblasts (CAFs) function as a double-edged sword in tumor progression. However, factors affecting the transition between tumor promotion and inhibition remain to be investigated. Here, we found that the transition was determined by stiffness heterogeneity of the tumor stroma in which tumor cells and CAFs were grown. When tumor cells were grown on a rigid plastic substrate, supernatants from CAFs inhibited the cytotoxic effects of 5-fluorouracil. In contrast, when tumor cells were grown on a soft substrate (5.3 kPa), supernatants from CAFs grown on a soft substrate increased the cytotoxicity of 5-fluorouracil. The diverse effects of CAFs were mediated by mechanotransduction factors, including stroma stiffness-induced cytokine expression in CAFs and signal transduction associated with stress fiber formation of CAFs. Moreover, we found that the cytokine expression in CAFs was regulated by nuclear Yesassociated protein, which changed according to cell stiffness, as characterized by atomic force microscopy. Overall, these findings suggested that modulating the mechanotransduction of the stroma together with CAFs might be important for increasing the efficacy of chemotherapy.
INTRODUCTION
Tumor tissues exhibit increased stiffness compared with normal tissues. Recent evidence has demonstrated that stroma stiffness plays important roles in the resistance of tumors to chemotherapy [1, 2] . Within stiff tissues, the distribution of stroma stiffness is often heterogeneous in different regions of the invasive tumor, in which geographically distinct regions display different constituents and architectures of the extracellular matrix [3, 4] . As an integral component of the tumor microenvironment, the extracellular matrix is mainly remodeled by carcinomaassociated fibroblasts (CAFs) [5] , which are activated by the altered matrix stiffness and solid stress and function to regulate tumor behaviors [6] [7] [8] . Increased crosslinking or assembly of extracellular matrix proteins leads to stiffening of the tumor stroma [9, 10] , which in turn enhances tumor progression by regulating the motility, proliferation, and even chemotherapeutic resistance of cancer cells [9, [11] [12] [13] . In our previous studies, we also demonstrated that mechanotypical factors alone can directly influence the effects of anticancer drugs, such as cisplatin, taxol, and lapatinib [14, 15] .
In addition to biomechanical factors, biochemical factors and nonmalignant cells, such as CAFs, immune cells, and endothelial cells in tumor microenvironment, can all affect therapeutic responses [16] [17] [18] . CAFs constitute a majority of the structural scaffold of solid tumors and play a critical role in tumor survival and progression via secretion of various growth factors, cytokines, and chemokines and degradation of extracellular matrix proteins [19] . However, CAFs are a double-edged sword whose effect on tumor is very inconsistent [20] . Some studies have shown that CAFs act as regulators to promote tu-morigenesis, metastasis, and resistance to anticancer drugs [6] , whereas other studies have demonstrated that CAFs act as inhibitory regulators of cancer progression, suppressing tumor proliferation and invasion [21] . These apparently opposite effects of CAFs have suggested that mechanotypical factors, such as differing stroma stiffness, may affect the mechanotransduction in CAFs, thereby modulating the effects of CAFs on tumor growth and phenotype. However, the specific mechanisms mediating these effects are still unknown.
Accordingly, in this study, we evaluated the effects of substrate stiffness and CCD-1095Sk human breast fibroblasts on the phenotypes of SK-BR-3 breast cancer cells. Our findings provide important insights into the effects of stroma stiffness heterogeneity on the mechanotransduction of CAFs and the role of CAFs as a doubleedged sword in antitumor therapy.
MATERIALS AND METHODS

Substrate preparation
Polydimethylsiloxane (PDMS) samples of different stiffnesses were prepared by modifying the ratio of the 'base' and 'curing agent' of SYLGARD 184 (Dow Corning) as follows: 60:1 (w/w; 46.7 kPa) and 80:1 (w/w; 5.3 kPa) [14] . After exposure to ultraviolet light at 365 nm for at least 5 h, the PDMS substrates were incubated with type I collagen (Gibco) at a concentration of 0.1 mg mL −1 for 24 h at 37°C. After washing with phosphate-buffered saline (PBS) twice, the substrates were soaked in the cell culture medium at 37°C for at least 30 min prior to the addition of cells.
Cell culture and preconditioned medium (PCM) preparation SK-BR-3 breast cancer cells (HTB-30; American Type Culture Collection [ATCC]) were cultured in RPMI1640 medium supplemented with 10% fetal bovine serum (FBS), 100 U mL −1 penicillin, and 100 mg mL −1 streptomycin (all from Hyclone) in a humidified incubator at 37°C (Sanyo) with 5% CO 2 . CCD-1095Sk human fibroblasts (CRL-2122; ATCC) were maintained in MEM medium (Gibco) supplemented with 10% FBS, 100 U mL −1 penicillin, 100 mg mL −1 streptomycin (all from Hyclone), 1.5 g L −1 sodium bicarbonate, and 0.11 g L −1 sodium pyruvate.
CCD-1095Sk cells were allowed to grow on the substrates with different stiffnesses until reaching 90% confluence, and only cells from passages 2-9 were used. PCM was prepared by filtering FBS-free RPMI1640 medium or medium containing inhibitors, which had been added to the culture dishes of CCD-1095Sk cells 48 h earlier. Finally, PCMs from different groups were normalized with fresh medium according to the cell number, which was determined using a cell-counting chamber at least three times per sample. Culture medium containing CCK-8 (Dojindo; 10:1, v/v) was applied as a working solution for cell viability testing. For each test, the supernatant was removed, and 100 μL CCK-8 working solution was added to each well; samples were incubated at 37°C for 3 h, and the absorbance at 450 nm (with reference wavelength of 650 nm) was then determined using a multimode plate reader (Enspire, PerkinElmer). The half-maximal inhibitory concentration (IC 50 ) was calculated by performing polynominal fit of the survival rate with OriginPro 2016.
Proliferation and cytotoxicity analysis
Immunostaining and imaging
After growing on substrates of different stiffnesses for 4 days, CCD-1095Sk cells were washed with PBS and fixed with 4% paraformaldehyde at 25°C for 30 min. The cells were permeabilized for 15 min with 0.25% Triton-X in PBS on ice, and nonspecific binding was blocked by incubating with 2% bovine serum albumin for 1 h at 37°C. The samples were then incubated at 4°C overnight with the primary antibody as indicated (anti-α-SMA Samples were mounted on microscope slides and imaged by fluorescence microscopy (Eclipse Ti-S, Nikon) equipped with a confocal system (UltraVIEW VoX, PerkinElmer). Images were acquired at 405, 488, and 560 nm excitation under the same conditions (exposure time, intensity, and sensitivity). The fluorescent signal was quantified using Volocity. Nuclear YAP or palladin intensity was determined according to the region confined by DAPI staining. Cytosolic YAP intensity was determined by the region confined by actin staining and without the region delimited by DAPI staining. For quantification of YAP nuclear localization, the ratio of YAP distribution between the cytoplasm and nucleus was analyzed in 35-70 cells for each experimental condition.
Atomic force microscopy (AFM)
CCD-1095Sk cells were cultured on substrates with different stiffnesses for at least three days before AFM measurements. To assess the elastic modulus of the cells, we used an AFM instrument (5500; Keysight) combined with an inverted microscope (TE2000U; Nikon). Each cell was probed to record the approach part of the forcedistance curves at the cell nucleus region at a frequency of 1 Hz. Silica spheres with a diameter of approximately 18 μm were attached to tipless AFM cantilevers (TL-CONT; Nanosensor) based on our previous method [22] . The force-distance curves were converted into force-indentation curves and fitted to the spherical Hertz model to calculate the Young's modulus of the CCD-1095Sk cells [23] . Before indention tests, the spring constant (K, 0.18 N m −1 ) of the cantilever was determined using the thermal tune method. The deflection sensitivity (S, 35.90 nm V −1 ) of the cantilever was measured in fluid according to the slope of the force-distance curves acquired on the glass substrate.
Analysis of human cytokine antibody array
Soluble cytokines in the prepared preconditioned medium (PCM) were detected using a Human Cytokine Array G5 (AAH-CYT-G5; RayBio), in which 80 human cytokines were included (Supplemental Table S1 ). The expression of each cytokine was determined by a fluorescence laser scanner. For each group without inhibitors, three biological replicates were used; only one replication assay was performed in PCM prepared with blebbistatin on a substrate with a stiffness of 46.7 kPa. According to the manufacturer's instructions, only average values of more than 50 were considered valid values.
Differences with more than 2-fold change or p values of less than 0.05 were considered significant.
Signaling manipulations
The nonmuscle myosin inhibitor blebbistatin (B0560; Sigma-Aldrich) and Rho-associated protein kinase (ROCK) inhibitor Y27632 (ab120129; Abcam) were used at 25 and 10 μmol L −1 , respectively. Prior to fluorescent imaging, cytokine detection, or AFM measurements, inhibitors were incubated with CCD-1095Sk cells for 48 h.
Statistical analysis
Data with homogeneous variances and following the normal distribution were expressed as the mean ± standard deviation, and a parametric statistical method (oneway ANOVA, Student-Newman-Keuls, or Student's ttests) was used to examine differences. For groups that did not follow the normal distribution or demonstrate nonhomogeneous variance, the median value was used to represent the data, and a nonparametric statistical method (Kruskal-Wallis test with NPAR1WAY procedure) was applied for statistical analysis. A p value < 0.05 was considered statistically significant. For each statistical analysis, at least three replicates were included, and the analysis was performed with SAS 9.0.
RESULTS
Substrate stiffness modulated the effect of CAFs on tumor cell proliferation
To investigate how stiffness heterogeneity of the tumor stroma induces the double-edged sword effect of CAFs on anticancer therapy, we first identified CAF markers in CCD-1095Sk human breast fibroblasts established from normal breast skin of a patient who had infiltrating ductal carcinoma. We found positive expression of CAF markers, such as fibroblast-activating protein (FAP; Fig. 1a ), α-smooth muscle actin (α-SMA; Fig. 1b ), and palladin (Supplemental Fig. S1 ) in CCD-1095Sk cells. In addition, cytokines and chemokines, such as interleukin (IL)-6, IL-8, IL-10, tumor necrosis factor (TNF), transforming growth factor (TGF)-β, and regulated upon activation, normal T cell expressed and secreted (RANTES) , which are known to be secreted by CAFs, were also detected in the PCM of CCD-1095Sk cells (Table S1 ) [6] . Taken together, our results suggest that CCD-1095Sk exhibited the CAFs characteristics. The stiffness of breast cancer tissue is increased by one order of magnitude compared with that of normal breast tissue [24] . PDMS with stiffnesses of 5.3 ± 0.2 and 46.7±2.1 kPa, both of which are physiologically relevant, was applied to mimic the heterogeneous stiffness of the mammary tumor stroma [3, 14] . These PDMS stiffness measurements were determined using an ElectroForce 3100, as described previously [14] . We then investigated the effects of PCM prepared from CCD-1095Sk cells growing on substrates of different stiffnesses (5.3 and 46.7 kPa, abbreviated as PCM/5.3 kPa and PCM/46.7 kPa, respectively) on the proliferation of SK-BR-3 breast cancer cells. Our results showed that PCM/46.7 kPa increased cell proliferation after four days relative to that of PCM/5.3 kPa on the rigid substrate (plastic) (F = 8.45, p < 0.05; Fig. 1c ). However, on soft substrate (5.3 kPa), tumor cell proliferation was increased by PCM/5.3 kPa compared with that of cells exposed to PCM/46.7 kPa and control medium (F = 9.79, p < 0.05; Fig. 1d ). Hence, our results suggested that the effects of CAFs on tumor cell proliferation appeared to be modulated by the stiffness of the substrate on which CAFs and tumor cells grew.
Diverse effects of PCM and substrate stiffness on tumor cell responses to the chemotherapeutic drug 5-FU
We then studied whether the PCM prepared on different substrate stiffness also influenced the responses of SK-BR-3 cells to 5-FU, which is widely used to treat breast cancer owing to its ability to halt cell division by interfering with the synthesis of DNA and RNA [25] . When SK-BR-3 cells were cultured on rigid plastic substrates, the survival rates of SK-BR-3 cells incubated with PCM were significantly increased at 5-FU concentrations of 0.008 and 0.04 mg mL −1 compared with that in the blank (no PCM) group (Fig. 1e) . IC 50 values were calculated to evaluate the effects of PCM. The results showed that the IC 50 value in the blank group (0.11 ± 0.04 mg mL Fig. 2a and Table S1 online), factors usually associated with cell proliferation and drug responses. The expression levels of GRO and ENA-78 were significantly increased in the PCM/5.3 kPa group compared with those in the PCM/ 46.7 kPa group (Fig. 2b and c) . Except for GRO and ENA-78, no obvious changes in other cytokines were identified between the PCM/5.3 kPa and PCM/46.7 kPa groups.
Substrate stiffness altered the nuclear distribution of YAP in CCD-1095Sk cells
We then investigated which pathways or targets in CCD- 1095Sk cells were associated with substrate stiffness and differential cytokine expression. YAP has been reported to act as a nuclear relay for mechanical signals originating from the rigidity of the extracellular matrix, which is mediated by Rho GTPase activity and tension of the actomyosin cytoskeleton [26] . YAP nuclear accumulation activates the expression of GRO and ENA-78 through binding with the promoter of target genes as a transcription factor [27, 28] . Hence, we next investigated whether YAP distribution in the nucleus was regulated by stiffness and resulted in differential GRO and ENA-78 expression. Employing confocal fluorescent microscopy, we observed that CCD-1095Sk cells grown on a stiffness of 5.3 kPa showed elevated nuclear distribution compared with cells grown on a stiffness of 46.7 kPa (Fig. 2d) . Moreover, quantitative analysis of YAP localization also showed that the nuclear/cytoplasmic ratio of cells grown on a substrate with 5.3 kPa stiffness was significantly higher than that of cells grown on a substrate with 46.7 kPa stiffness (χ 2 = 5.97, p < 0.05; Fig. 2e ). The median (minimum-maximum) nuclear/cytoplasmic ratios of YAP in the 5.3 and 46.7 kPa groups were 0.27 (0.19-0.56) and 0.24 (0.14-0.33), respectively. Because stress fibers play critical roles in the translocation of YAP from the cytoplasm to the nucleus, we next analyzed the stiffnesses of CCD-1095Sk cells and the stress fibers of these cells in relation to the substrate stiffness. Cells on a stiff substrate showed prominent stress fibers throughout the cytoplasm; in contrast, cells on a soft substrate (5.3 kPa) only formed dispersed stress fibers at the outer edge (Fig. 2d) 
Stress fiber inhibitors modified the effects of CAFs on the survival of SK-BR-3 cells grown on the PDMS substrate
To further define the roles of stress fibers in the mechanotransduction of CAFs, stress fiber formation was inhibited by the nonmuscle myosin inhibitor blebbistatin (25 μmol L −1 ) or ROCK inhibitor Y27632 (10 μmol L −1 ) [29] . Cytokine array analysis showed that the expression of soluble cytokines in the PCM/46.7 kPa group was downregulated after blebbistatin treatment ( Fig. 3a and Table S2 ). Most downregulated cytokines were involved in the progression and growth of tumors. In particular, the expression levels of GRO and ENA-78 were decreased by 3.78-and 3.03-fold, respectively (Fig. 3b) . Our results suggested that the secretion of soluble factors was regulated by stress fiber structures, which could be modulated by substrate stiffness. We further investigated the relationships of stress fiber formation, substrate stiffness, PCM of CAFs, and cancer cell survival in response to 5-FU. Before the experiment, we confirmed that blebbistatin and Y27632 did not have cytotoxic effects on cancer cells grown on PDMS with a stiffness of 5.3 kPa, with or without PCM (Fig. S3) . SK-BR-3 cells exposed to different 5-FU concentrations were incubated with PCMs prepared from CCD-1095SSK cells treated with either blebbistatin or Y27632 on stiffnesses of 5.3 and 46.7 kPa. When SK-BR-3 cells were grown on PDMS with a stiffness of 5.3 kPa, the difference in survival between PCM/5.3 kPa and PCM/46.7 kPa groups was abrogated in the presence of blebbistatin (Fig. 3c) or Y27632 (Fig. 3d) . These results indicated that stress fiber formation of CAFs played an essential role in regulating the responses of cancer cells to 5-FU.
Stress fiber inhibitors reduced the nuclear distribution of YAP in CCD-1095Sk cells
Because YAP nuclear translocation was mediated by stress fibers, we further investigated whether stress fiber inhibitors changed the YAP nuclear distribution of CCD1095Sk cells. We found that YAP nuclear distributions in CCD-1095Sk cells on a less-stiff substrate (5.3 kPa) and stiffer substrate (46.7 kPa) were both reduced after blebbistatin or Y27632 treatment (Fig. S4) . Furthermore, based on the confocal imaging, no obvious differences in YAP expression and nuclear distribution were observed between CCD-1095Sk cells grown on substrates with 5.3 and 46.7 kPa stiffness after blebbistatin or Y27632 treatment (Fig. 4a) . Quantitative YAP fluorescence intensity in the nucleus versus cytoplasm showed no significant differences in nuclear/cytoplasmic ratios between CCD1095Sk cells grown on substrates with 5. showed that stress fiber inhibitors abrogated alterations in YAP nuclear distribution resulting from differences in the substrate stiffness on which CCD-1095Sk cells were grown. The structures of stress fiber upstream of YAP translocation were also affected by the inhibitors. For example, organized stress fibers were significantly decreased in CCD-1095Sk cells grown on stiffnesses of 5.3 and 46.7 kPa after treatment with blebbistatin or Y27632 (Fig. 4b) . Consistent with these results, stiffness differences in CCD-1095Sk cells grown on substrates with stiffnesses of 5.3 and 46.7 kPa were also abolished upon treatment with blebbistatin (χ 2 = 0.03, p = 0.85, Fig. 4c, iii) or Y27632 (χ 2 = 0.44, p = 0.51, Fig. 4c, iv) . After blebbistatin and Y27632 treatment, the median values (minimum-maximum) for Young's modulus of CCD1095Sk cells grown on the substrate with 5.3 kPa stiffness were 6.80 (2.51-12.13) and 6.25 (2.57-15.82) kPa, respectively, whereas those of cells grown on the substrate with 46.7 kPa stiffness were 7.48 (2.84-11.22) and 5.90 (2.66-14.72) kPa, respectively. We further found that the stiffness of CCD-1095Sk cells grown on the substrate with 46.7 kPa stiffness was significantly decreased by the inhibitors, whereas that of cells grown on the substrate with 5.3 kPa stiffness did not change (Fig. S5) .
DISCUSSION
The tumor microenvironment demonstrates a heterogeneous distribution of both its biological/biochemical constitutes and biomechanical properties, which play critical roles in regulating tumor cell phenotypes, including proliferation, invasion, metastasis, and treatment response [3, 4] . Nonmalignant stromal cells, such as fibroblasts, immune cells, vascular cells, and even neurons in the tumor microenvironment, have diverse biochemical effects that can be either beneficial or detrimental [30] [31] [32] . The mechanisms for such a divergent, often opposite, effect are unclear. Here, for the first time, we found that stroma substrates played important roles in inducing CAFs as a double-edged sword in cancer cell cocultured on plastic systems [33] [34] [35] . Stromal fibroblasts of pancreatic ductal adenocarcinoma tissues in mice promote the suppression of tumor growth upon ganciclovir administration [20, 21] . Additionally, Liu et al. [2] found that biophysical cues in vivo, specifically matrix stiffness, were potential targets of mesenchymal stem cell-based vectors for cancer treatment, whereas manipulating stroma stiffness may affect the outcomes of cancer treatment. Similarly, we found that when tumor cells were grown on soft PDMS substrates (5.3 kPa), PCM also prepared on the 5.3 kPa substrate led to inhibition of tumor cell survival in response to 5-FU, whereas PCM prepared on a stiffer substrate (46.7 kPa) had no obvious effect.
The widely investigated antitumor agents include chemo drugs, targeted drugs, and recently developed nanoparticles, such as nanorods and nanocrystals, which are used for photothermal therapy [36, 37] . Cytokine crosstalk between tumor cells and CAFs is responsible for drug resistance [38] . In CCD-1095Sk cell supernatants, we detected abundant expression of cytokines, such as TGF-β, VEGF, RANTES, IL-6, ENA-78, GRO, MCP-1, SCF, TNF, angiotensin, osteoprotegerin, leukemia inhibitory factor, MIF, and TIMP. TGF-β on a stiff substrate has been reported to be a critical mediator of fibroblast/tumor crosstalk, modulating 5-FU resistance via activation of the epithelial-mesenchymal transition (EMT) process or protection of breast cancer cells from DNA damageinduced apoptosis via inhibition of p53 [38, 39] . Moreover, studies have shown that the chemotherapy resistance conferred by TGF-β is abrogated by decreasing stiffness, which inhibits the TGF-β-induced EMT [40, 41] . Because no significant differences in TGF-β secretion were detected between PCM/5.3 kPa and PCM/46.7 kPa groups (Fig. S6) , we examined other mechanisms, specifically cytokines such as GRO and ENA-78, which showed elevated secretion in the PCM/5.3 kPa group. Indeed, on soft PDMS substrate, GRO and ENA-78 promoted cell cycle progression in tumor cells and thus increased sensitivity to 5-FU [42, 43] . The secretion of GRO and ENA-78 is regulated by nuclear localization of YAP, a mechanosensitive transcriptional co-activator that plays various roles in tissue homeostasis, organ development, and oncogenic transformation [44] . YAP nuclear accumulation in fibroblasts is known to be positively correlated with substrate stiffness, which can vary from less than 500 Pa to more than 10 kPa [29, 45] . Another study further confirmed that apart from substrate stiffness, molecular clutches also play critical roles in YAP translocation, which is promoted on intermediate-stiffness substrates and collapsed on high-stiffness substrates by increasing the ligand spacing [46] . Consistent with the previous findings, we demonstrated that collagen-coated PDMS with a stiffness of 5.3 kPa promoted more YAP nuclear accumulation compared with PDMS with a stiffness of 46.7 kPa, which accounted for the increased expression of GRO and ENA-78 in the PCM/5.3 kPa group. We also find that YAP nuclear translocation was inhibited by the stress fiber inhibitors, suggesting that YAP functioned downstream of stress fiber in mechanotransduction of stiffness.
Despite obvious limitations, such as the in vitro nature of the study, and the use of a single cell line/single chemotherapeutic drug, our study still provided strong evidence that the complex interplay among tumor cells, stromal cells (CAFs), and mechanical factors in the tumor microenvironment contributed to the observed malignant phenotypes, including tumor proliferation and drug response. Fig. 5 demonstrates the double-edged sword behaviors of CAFs. We hypothesize that CAFs sense the stiffness of the extracellular matrix by mechanotransduction of the integrin complex, which couples with ROCK to deliver mechanical signals to stress fibers. Stress fibers transmit extracellular mechanical signals and mediate YAP nuclear translocation through Hippo signaling. In the nucleus, YAP combines with the TEAD family of transcription factors and activates the secretion of cytokines, such as TGF-β, GRO, and ENA-78, which regulate the proliferation of cancer cells [47] . When tumor cells were grown on the rigid substrate, TGF-β promoted tumor survival; in contrast, when tumor cells and CAFs were both grown on the soft substrate (5.3 kPa), nuclear YAP inhibited cancer cell growth by upregulation of GRO and ENA-78 expression in CAFs. This process could be suppressed using inhibitors of nonmuscle myosin or ROCK, which disrupted the structures of stress fibers.
Tumors are known to exhibit heterogeneous features [48, 49] . In fact, although the tumor stroma is often stiff, the tumor cells themselves are soft [50] . Stiffness heterogeneity influences cytokine crosstalk in tumor-stromal interfaces and modulates chemotherapy responses. Combined with our recent studies, these findings suggest that mechanical factors in the tumor microenvironment function not only via direct regulation of cell mechanotransduction [14, 15] , but also by modulating tumorstromal cell interactions, which have critical implications for clinical cancer treatment and drug screening. Recent studies have focused on the tumor microenvironment for the development of pharmacological strategies to inhibit cancer because stromal cells are genetically stable and can be re-educated for normalization [31] . Based on these new strategies, stromal cells and cytokines have been targeted by various agents, such as small molecules, antibodies, and nanoparticles [51, 52] ; however, satisfactory efficacy in the clinical setting has not been achieved, likely owing to the double-edged sword effect conferred by stiffness heterogeneity. Hence, integral regulation of the tumor mechanical microenvironment combined with chemotherapy or target therapy may be a better approach for cancer treatment.
CONCLUSIONS
In conclusion, stiffness heterogeneity induced the doubleedged sword behaviors of CAFs in anticancer therapy. In response to changes in the mechanical microenvironment, CAFs regulate their stiffness and mechanotransduction, such as stress fiber formation, nuclear YAP distribution, and cytokine secretion, which further influence tumor proliferation and chemotherapeutic efficacy. Thus, mechanical intervention of the tumor microenvironment should be an important component of the overall anticancer drug design and treatment, which can be regarded as a relevant biomechanopharmacology strategy [53, 54] .
Figure 5
Illustration of the mechanism of the double-edged sword effect of CAFs on tumor drug responses. CAFs sense the stiffness of the extracellular matrix by mechanotransduction of the integrin complex, which delivers the mechanical signal to stress fibers. Stress fibers transmit extracellular mechanical signals and mediate YAP nuclear translocation, which then activates the secretion of cytokines from CAFs. When tumor cells were grown on the rigid substrate, TGF-β promoted tumor survival. When tumor cells and CAFs were both grown on the soft substrate (5.3 kPa), nuclear YAP inhibited cancer cell growth by upregulation of GRO and ENA-78 expression in CAFs. The process was suppressed by blebbistatin or Y27632, which disrupted the structures of stress fibers.
